Phase II Trial of Hypomethylating Agent Combined with Nivolumab for Acute Myeloid Leukaemia Relapse after Allogeneic Haematopoietic Cell Transplantation-Immune Signature Correlates with Response.
BRITISH JOURNAL OF HAEMATOLOGY（2023）
关键词
acute myeloid leukaemia,allogeneic haematopoietic cell transplantation,hypomethylating agent,immune checkpoint inhibition,immune phenotype,relapse,single-cell immunomonitoring,single-cell RNA-sequencing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要